Goldenwell Biotech (GWLL) Other Non-Current Liabilities (2022 - 2025)
Goldenwell Biotech (GWLL) has disclosed Other Non-Current Liabilities for 4 consecutive years, with $189250.0 as the latest value for Q3 2025.
- For the quarter ending Q3 2025, Other Non-Current Liabilities fell 11.91% year-over-year to $189250.0, compared with a TTM value of $189250.0 through Sep 2025, down 11.91%, and an annual FY2024 reading of $189250.0, up 170.36% over the prior year.
- Other Non-Current Liabilities was $189250.0 for Q3 2025 at Goldenwell Biotech, roughly flat from $189250.0 in the prior quarter.
- Across five years, Other Non-Current Liabilities topped out at $214838.0 in Q2 2024 and bottomed at $20000.0 in Q4 2022.
- Average Other Non-Current Liabilities over 4 years is $135188.7, with a median of $177419.0 recorded in 2024.
- The sharpest move saw Other Non-Current Liabilities surged 329.68% in 2024, then dropped 11.91% in 2025.
- Year by year, Other Non-Current Liabilities stood at $20000.0 in 2022, then soared by 250.0% to $70000.0 in 2023, then soared by 170.36% to $189250.0 in 2024, then changed by 0.0% to $189250.0 in 2025.
- Business Quant data shows Other Non-Current Liabilities for GWLL at $189250.0 in Q3 2025, $189250.0 in Q2 2025, and $189250.0 in Q1 2025.